Ultromics

❤️ Spotlight on EchoGo® Heart Failure for HFpEF detection EchoGo® Heart Failure leverages advanced AI and cardiac imaging to identify patients with Heart Failure with Preserved Ejection Fraction (HFpEF). It provides diagnostic outputs that assist healthcare professionals in diagnosing, managing, and optimizing treatment responses for patients. The technology has been scientifically validated in peer-reviewed journals, demonstrating its efficacy in improving the detection and supporting diagnosis of this challenging subtype of heart failure. Discover the latest research and use cases: ❤️ Clinical Deployment of Ultromics EchoGo® HFpEF Algorithm at Northwestern https://hubs.la/Q02H5rzh0 ❤️Comparison of an Artificial Intelligence Heart Failure Detection Model and Clinical Prediction Models in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) at Beth Israel Deaconess Medical Center and Harvard Medical School https://hubs.la/Q02H5xF_0 ❤️ Unmasking HFpEF with Artificial Intelligence: A Disruptive Opportunity for Disease Detection. https://hubs.la/Q02H5V0_0 ❤️ Automated Echocardiographic Detection of Heart Failure With Preserved Ejection Fraction Using Artificial Intelligence. https://hubs.la/Q02H5FbY0 ❤️Artificial Intelligence to Aid Early Detection of Heart Failure With Preserved Ejection Fraction https://hubs.la/Q02H5GWt0 ❤️ Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics. https://hubs.la/Q02H5KRX0 #EchoGo #Ultromics #HFpEF #HeartFailure #Cardiology #AIinHealthcare #Innovation

❤️Tomorrow is World Amyloidosis Day, we're shining a light on cardiac amyloidosis and the importance of early diagnosis. Detecting the condition early is vital to improving patient care, but it can be challenging due to the wide range of symptoms and risk factors, making it difficult to spot warning signs. Our blog explores these early warning signs, highlights the populations most at risk, and the differences between AL and ATTR Amyloidosis treatments. We also look at promising future therapies that could offer hope to those affected. Read the full article here: https://hubs.la/Q02VRCp00 #WorldAmyloidosisDay2024 #Amyloidosis #Ultromics #EchoGo #PatientsFirst #HeartHealth #AIinHealthCare

Our new clinical research dossier includes Ultromics' latest advancements and studies, highlighting cutting-edge innovations in Echo-based diagnostics. This research has been instrumental in advancing the detection of cardiovascular diseases and heart failure. The studies have been published in peer-reviewed journals such as JACC: Advances and JASE, and presented at major conferences. 📖 See our brochure to learn more about our clinical validation and how we’re supporting clinical decision-making and enhancing patient care: https://hubs.la/Q02TPBJT0 #HFpEF #Ultromics #EchoGo #Amyloidosis #HeartFailure #Cardiology #HeartHealth #PatientsFirst #AIinHealthCare

Dr. Akhil Narang discusses the early experience and clinical impact of EchoGo® Heart Failure at Northwestern and how it integrates with their workflow. 💡 From an initial cohort of 532 patients, EchoGo® Heart Failure identified 117 patients as suggestive of HFpEF—52% of whom did not have HFpEF noted in their chart. 🔍 Several patients had incomplete HFpEF scores, often due to missing TR signals. EchoGo® Heart Failure was able to detect HFpEF even when data was incomplete or missing. ✔️ EchoGo® Heart Failure flagged 5-6 cases daily which could then be referred to clinic for further care. 📈 Northwestern also had positive reimbursement outcomes. EchoGo® Heart Failure is eligible for $1,024 per inpatient study and $285 per outpatient study. Watch the full case study here: https://lnkd.in/e4R5Mg2h EchoGo® Heart Failure uses AI to help clinicians detect HFpEF, addressing the limitations of manual scoring. The technology offers the potential for earlier interventions and improved patient management. Learn more: https://lnkd.in/gdZvPene #HFpEF #HeartFailure #Ultromics #EchoGo #PatientsFirst #AIinHealthcare #CardiologyInnovation

Hear from our founder & CEO Ross Upton as he explains how Ultromics has navigated achieving reimbursement for EchoGo® Heart Failure as an AI diagnostic aid in echo.

Check out the latest substack ‘Reimbursement for AI in Echo’ from our Founder, CEO and Chief Scientific Officer Ross Upton, PhD

This year Ultromics is participating in #MICCAI in multiple events: --> Workshop: #ASMUS workshop (https://lnkd.in/egRewY4C): I am, co-chairing this event, focused on the latest advances and research on ultrasound imaging, with a strong emphasis in AI techniques, for a variety of medical applications. *6th October, 8:00 to 12:30 (local time), Oliveraie Meeting Room* --> Oral Presentation: "Multi-Site Class-Incremental Learning with Weighted Experts in Echocardiography", presented by Kit Bransby at #ASMUS In a nutshell: How to train AI models with a large amount of data when data is split into different sites, or available at different times? Kit proposes a new technique that prevents re-training from scratch every time, achieves top performance, and provides interpretable results! *6th October, 8:50 to 9:30 Oliveraie Meeting Room* --> Poster Presentation: "BackMix: Mitigating Shortcut learning in Echocardiography with Minimal Supervision", presented by Kit Bransby (MICCAI-Main Conference) - Poster T-AM-037 In a nutshell: Most AI enabled ultrasound methods require a manual preprocessing step that is costly and prone to error. Here we propose a novel augmentation approach that removes the need for such preprocessing! *8th October, 10:30 to 11:30 Poster Session 3, Palmeraie Conference Center* --> Poster Presentation: "EchoNet-Synthetic: Privacy-preserving Video Generation for Safe Medical Data Sharing", collaborating with Imperial College London, presented by Hadrien Reynaud (MICCAI-Main Conference) - Poster W-PM-090 In a nutshell: sharing medical data is challenging and sometimes impossible. In this work Hadrien proposes a way of synthetically generate data that preserves privacy as well as bringing in other convenient properties, addressing this challenge! *9th October, 15:00 to 16:30 Poster Session 6, Palmeraie Conference Center* Please come to the #ASMUS workshop and come talk to Jorge Miguel Gomes de Oliveira , Kit Bransby, Hadrien Reynaud or myself if you are around MICCAI'24! See you all in Marrakesh!

Our recent study at Mayo Clinic found that EchoGo® Heart Failure can identify #HFpEF patients at high risk of HF hospitalization and cardiac mortality, with incremental risk according to categorical and probability outputs. This marks a significant step forward in AI-driven cardiac care, offering clinicians an advanced tool to help predict outcomes and manage patients more effectively. Integrating EchoGo® Heart Failure into existing clinical pathways provides a precise approach to identifying patients at risk of heart failure hospitalization, potentially revolutionizing early interventions and improving long-term outcomes for heart failure patients. For more details, check out the full poster here: https://lnkd.in/ef4U44Va #Ultromics #EchoGo #HFpEF #Cardiology #HeartFailure #HeartHealth #AIinHealthCare #PatientsFirst

Ultromics will be at HFSA this weekend! Our latest research in collaboration with Mayo Clinic will be presented by our Senior Clinical Research Scientist Ashley Akerman. Mark it in your diary to hear how EchoGo® was able to support clinicians in identifying HFpEF patients at high risk of rehospitalization and mortality. Stop by booth 336 to learn how Ultromics is revolutionizing heart failure care and supporting clinicians in detecting complex heart failure subtypes like HFpEF.. "AI-based Echocardiographic Assessment Is Associated With HF Hospitalization and Cardiac Mortality in HFpEF." 🗓️ Saturday, 28th September  🕒 8:09 AM - 8:19 AM (Session starts at 7:45 AM)  📍 Exhibit Hall C - Oral Abstract Stage  👨🔬Ashley Akerman, PhD #EchoGo #Ultromics #HFpEF #HeartFailure #AIHealthCare #Cardiology 

🎉Ultromics is excited to announce we are finalists in The Digital Health Hub Foundation - Digital Health Awards 2024 as 1 of 4 in the Provider Diagnostic – Best in Class, selected from over a thousand submissions globally! The Awards recognize health technologies driving significant change in healthcare. Our platform, EchoGo® is a first of its kind AI powered solution applying advanced AI to echocardiograms to support clinicians in the diagnosis of complex heart failure subtypes like HFpEF. #Ultromics #EchoGo #HeartFailure #HFpEF #Cardiology #PatientsFirst #Innovation #AIHealthCare #HealthcareAwards